Delivery Order SPE2DR25D2009-SPE2DR26FJ5B4
- Not listed
- The Defense Logistics Agency awarded a $1,129.04 firm fixed price delivery order to AmerisourceBergen Drug Corp for Clonidine 0.3 mg/day patches (4-patch set) with an ultimate completion date of September 16, 2025. This award represents a competitively awarded, non-set-aside contract issued to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Clonidine 0.3 mg/day patches (4-count units) with a firm fixed price ceiling value of $1,263.96. The contract is non-competed and carries an ultimate completion date of December 4, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,560.14 firm fixed-price contract is for the delivery of the prescription medication Clonidine 0.3 mg/day patches. The contract has an ultimate completion date of July 3, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not designated as a set-aside. The company holds a...
- The Defense Logistics Agency awarded a $1,008.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4 boxes of 0.3 mg/day Clonidine patches. The contract has a period of performance from September 21, 2023 through September 22, 2023. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will fulfill the order from its facility located in Conshohocken, Pennsylvania. The Defense Logistics Agency functions to support the resupply needs...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of clonidine 0.1 mg/day patches. The contract, valued at $1,109.43, has a completion date of July 11, 2023, and is not designated as a set-aside. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on September 8, 2025, for Clonidine HCl ER 0.17 mg tablets (30-count supply) with a ceiling value of $1,491.84. This firm fixed-price, competitively awarded contract carries an ultimate completion date of September 9, 2025, and involves no set-aside designation. The delivery order represents a single transaction under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a $486 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561772171 CLONIDINE 0.1 MG/DAY PATCH 4S. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania under a one-day period of performance from August 10-11, 2023. As a major provider of medical supplies and logistics support to the U.S. Department of Defense, this order for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,773.53 firm fixed-price delivery order is for the supply of 4,566,151,192 units of clonidine 0.2 mg/day transdermal patches. The award has an ultimate completion date of October 21, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,714.84 delivery order is for the supply of Clonidine 0.3 mg/day patches. The contract has a firm fixed price and was not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,010.21 firm fixed-price delivery order is for the supply of the medication Clonidine 0.2 mg/day patches. The contract has an ultimate completion date of September 14, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- SPE2DR25D2009Indefinite Delivery Contract
- SPE2DR25D2009-SPE2DR26FJ5B4Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,716.55 to AmerisourceBergen Drug Corp for the supply of Clonidine 0.3 mg/day patches (4-week supply) on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price, non-set-aside contract was awarded competitively and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement needs, particularly for military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive capability in supplying a comprehensive range of pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. This delivery order for Clonidine, a commonly prescribed antihypertensive medication, exemplifies the routine pharmaceutical supply operations that support the Defense Health Agency and other government healthcare systems through the DLA's established pharmaceutical prime vendor framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 1/11/26 |